The Association of Community Cancer Centers (ACCC) annual awards are designed to confer special recognition on members of the oncology community who have distinguished themselves in service to their patients, local community, the oncology profession, and the Association.
Since 2011, the ACCC Innovator Award honors forward-thinking Cancer Program Members for their ingenuity and pioneering achievements in oncology. Their innovative work contributes significantly to improve access, quality, and value in the delivery of cancer care across the United States. The application process for the 2019 Innovator Awards is now open. The submission deadline is Friday, March 8, 2019.
Since 1980, the Annual Achievement Award has been given to distinguished individuals or organizations who have reflected the values of community cancer care through their outstanding contributions.
Otis Webb Brawley, MD, MACP
Chief Medical and Scientific Officer; Executive Vice President, Research
American Cancer Society
Otis Webb Brawley, MD, MACP, is an acknowledged global leader in the field of cancer prevention and control. As the chief medical and scientific officer and executive vice president of the American Cancer Society, he is responsible for promoting the goals of cancer prevention, early detection, and quality treatment through cancer research and education. He champions efforts to decrease smoking, improve diet, and provide the critical support cancer patients need. He also guides efforts to enhance and focus the nation's research program, upgrade the Society's advocacy capacity, and concentrate community cancer control efforts in areas where they will be most effective.
Dr. Brawley has served on a number of advisory committees including the NIH Committee on Women’s Health; the Centers for Disease Control and Prevention Advisory Committee on Breast Cancer in Young Women; the Centers for Disease Control and Prevention Breast and Cervical Cancer Early Detection and Control Advisory Committee; and the Food and Drug Administration Oncologic Drug Advisory Committee.
He has been listed as one of America's Top Doctors for Cancer by Castle Connolly, was the recipient of the key to St. Bernard Parish for his work in the U.S. Public Health Service in the aftermath of Hurricane Katrina, and is a fellow of the American College of Epidemiology and one of fewer than 1,300 physicians to be named a Master of the American College of Physicians in its more than 100-year history.
Dr. Brawley graduated from the University of Chicago, Pritzker School of Medicine; trained in internal medicine at Case Western Reserve University and medical oncology at the National Cancer Institute.
The Clinical Research Award recognizes individuals whose research has significantly and positively impacted the oncology patient, family, or community.
Patricia A. Ganz, MD
UCLA School of Medicine
Patricia A. Ganz, MD, has been a member of the faculty of the UCLA School of Medicine since 1978 and the UCLA School of Public Health since 1992. In 1999, she was awarded an American Cancer Society Clinical Research Professorship for "Enhancing Patient Outcomes Across the Cancer Control Continuum," and in 2007, was elected to the Institute of Medicine, U.S. National Academy of Sciences.
A recipient of the Susan G. Komen Foundation Professor of Survivorship Award, Dr. Ganz is a pioneer in the assessment of quality of life in cancer patients and survivors and is active in clinical trials research with the National Surgical Adjuvant Breast and Bowel Project (NSABP), focusing much of her clinical and research efforts in the areas of breast cancer and its prevention. Her other major areas of research include cancer survivorship and late effects of cancer treatment, cancer in the elderly, and quality of care for cancer patients. In 1997, she established the UCLA Family Cancer Registry and Genetic Evaluation Program, which serves patients, survivors, and those at high risk for familial/hereditary cancers.
Dr. Ganz is an associate editor for the Journal of the National Cancer Institute as well as the CA—A Cancer Journal for Clinicians, and is on the editorial board of the Journal of Cancer Survivorship. She was a founding member of the National Coalition for Cancer Survivorship (NCCS) in 1986 and has been directing the UCLA—LIVESTRONG Survivorship Center of Excellence at Jonsson Comprehensive Cancer Center since 2006.
The David King Community Clinical Scientist Award recognizes active community clinical research leaders who have demonstrated leadership in the development, participation, and evaluation of clinical studies and/or are active in the development of new screening, risk assessment, treatment, or supportive care programs for cancer patients.
James L. Wade III, MD, FACP, FASCO
Medical Oncologist, Founder
Cancer Care Specialists of Illinois
James L. Wade III, MD, FACP, FASCO, is an active leader in cancer research and works as both a committee chair and a board member of several NCI-sponsored national and international research organizations. He has served as the director of medical oncology at Decatur Memorial Hospital and has been the principal investigator of the NCI-sponsored Central Illinois Community Clinical Oncology Program since 1991. An associate professor of clinical medicine, Dr. Wade also teaches and mentors young physicians at the Feinberg School of Medicine, Northwestern University in Chicago.
Dr. Wade has developed the Cancer Care Specialists of Illinois (CCSI) into the largest interdisciplinary oncology hematology practice in Illinois outside of Chicago. CCSI—and its 20 board certified physicians—is nationally recognized as an outstanding cancer care practice and recipient of the Quality Oncology Practice Initiative (QOPI) Certification from the American Society of Clinical Oncology.
Dr. Wade earned his medical degree from the University of Illinois College of Medicine, Abraham Lincoln School of Medicine in Chicago, Illinois. After completing his residency in internal medicine in 1981, Dr. Wade served as the chief resident in medicine at the University of Illinois Hospital in Chicago. In 1984, he completed a fellowship in hematology/oncology at the University of Chicago.